Buscar resultados de ensayos clínicos
Cysts - 80 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Complete Twelve Month Bone Remodeling With a Bi-phasic Injectable Bone Substitute in Benign Bone Tumors Condición: Bone Cyst Fecha: 2015-09-30 Intervenciones: Device: CERAMENT™ |BONE VOID FILLER Implantation of bi-phasic ceramic bone substitute to provide b |
Recruiting |
Nombre del estudio: Calcium Phosphate Cement Registry (CPC Registry) Condición:
|
Completed |
Nombre del estudio: Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) Condición:
Fecha: 2011-07-05 Intervenciones: Biological: MSV treatment Autologous maxillary bone marrow mesenchymal stem cells (MSV-H) collected from |
Enrolling by invitation |
Nombre del estudio: Gene-activated Bone Substitute for Maxillofacial Bone Regeneration Condición:
|
Enrolling by invitation |
Nombre del estudio: Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects Condición: Grafting, Bone Fecha: 2005-09-12 Intervenciones: Device: MBCP-Gel (tm) |
Completed |
Nombre del estudio: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face Condición: Neoplastic Syndrome Fecha: 2007-06-20 Intervenciones: Drug: tazarotene Tazarotene is a member of the acetylenic class of retinoids. |
Completed |
Nombre del estudio: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back Condición: Skin Carcinoma Fecha: 2008-10-31 Intervenciones:
|
Withdrawn |
Nombre del estudio: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condición: Basal Cell Carcinoma Fecha: 2010-07-06 Intervenciones:
|
Recruiting |
Nombre del estudio: Familial Investigations of Childhood Cancer Predisposition Condición:
|
Completed |
Nombre del estudio: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients Condición: Basal Cell Nevus Syndrome Fecha: 2016-04-27 Intervenciones:
|